TOWA PHARMACEUTICAL CO., LTD.

Press Releases Towa Pharmaceutical Co., Ltd.

Equities

4553

JP3623150004

Market Closed - Japan Exchange Other stock markets 07:00:00 10/05/2024 BST			5-day change	1st Jan Change
2,777 ^JPY	+1.61%		-1.03%	+18.07%

03-25	Towa Pharmaceutical Completes Payment for Director Stock Compensation	MT
03-07	VIE STYLE, Inc. announced that it has received ¥305 million in funding from Otsuka Holdings Co., Ltd., KAYAC Inc., Taisho Pharmaceutical Holdings Co., Ltd., Towa Pharmaceutical Co., Ltd., PE&HR Co., Ltd., Murata Manufacturing Co., Ltd. and other investors	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Towa Pharmaceutical : FY2023(1st quarter) Summary of Consolidated Financial Results for the Three Months Ended June 30, 2023(Based on Japanese GAAP) (375K/7P)	10/08/23	PU
Towa Pharmaceutical : FY2023(1st quarter) Supplementary Material of Financial Results (1.03M/28P)	10/08/23	PU
Towa Pharmaceutical : Notice of the 67th Ordinary General Meeting of Shareholders （176KB／10P）	31/05/23	PU
Towa Pharmaceutical : FY2022 Supplementary Material of Financial Results (1.2M/42P)	15/05/23	PU
Towa Pharmaceutical : FY2022(4th quarter) Summary of Consolidated Financial Results for the Year Ended March 31, 2023(Based on Japanese GAAP) (616K/10P)	15/05/23	PU
Towa Pharmaceutical : 2023年3月期決算短信〔日本基準〕（連結）	15/05/23	PU
Chugai and Towa Launch Edirol Tablet for Osteoporosis Treatment	09/12/22	AQ
TOWA PHARMACEUTICAL : INTEGRATED REPORT 2021	21/12/21	PU
Chugai - Towa Pharmaceutical Receives Approval for Authorized Generic Version of Chugai's Osteoporosis Agent Edirol	06/12/21	AQ
Towa Pharmaceutical : Breckenridge Pharmaceutical, Inc. - Towa completes acquisition of Esteve's Generic Division	03/02/20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer